Huaren Pharmaceutical Co Ltd (300110) — Cash Flow Reinvestment Rate
Huaren Pharmaceutical Co Ltd (300110) has a Cash Flow Reinvestment Rate of 0.08x as of September 2025, reinvesting CN¥7.00 Million (capex CN¥7.00 Million ) from operating cash flow of CN¥86.78 Million. Check earnings quality score of Huaren Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Huaren Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Huaren Pharmaceutical Co Ltd across 17 annual periods. Explore Huaren Pharmaceutical Co Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Huaren Pharmaceutical Co Ltd (2007–2025)
Year-by-year capital reinvestment analysis for Huaren Pharmaceutical Co Ltd. For live market cap and broader valuation context, see market cap of Huaren Pharmaceutical Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.13x | CN¥49.34 Million | CN¥390.23 Million | CN¥48.98 Million | ▲ +62.3% |
| 2024 | 0.08x | CN¥25.11 Million | CN¥322.36 Million | CN¥24.69 Million | ▼ -48.4% |
| 2023 | 0.15x | CN¥46.16 Million | CN¥305.60 Million | CN¥45.86 Million | ▼ -82.3% |
| 2022 | 0.85x | CN¥186.14 Million | CN¥217.98 Million | CN¥42.33 Million | ▲ +657.5% |
| 2019 | 0.11x | CN¥34.87 Million | CN¥309.33 Million | CN¥32.02 Million | ▼ -49.3% |
| 2018 | 0.22x | CN¥56.58 Million | CN¥254.32 Million | CN¥45.47 Million | ▼ -55.0% |
| 2017 | 0.49x | CN¥104.47 Million | CN¥211.08 Million | CN¥87.36 Million | ▼ -73.3% |
| 2016 | 1.86x | CN¥337.17 Million | CN¥181.65 Million | CN¥168.95 Million | ▼ -80.0% |
| 2015 | 9.26x | CN¥173.84 Million | CN¥18.77 Million | CN¥156.73 Million | ▲ +133.8% |
| 2014 | 3.96x | CN¥259.80 Million | CN¥65.56 Million | CN¥259.80 Million | ▼ -30.8% |
| 2013 | 5.72x | CN¥227.69 Million | CN¥39.78 Million | CN¥227.69 Million | ▲ +110.5% |
| 2012 | 2.72x | CN¥270.43 Million | CN¥99.44 Million | CN¥270.43 Million | ▼ -30.5% |
| 2011 | 3.91x | CN¥232.83 Million | CN¥59.53 Million | CN¥232.83 Million | ▲ +352.4% |
| 2010 | 0.86x | CN¥67.10 Million | CN¥77.61 Million | CN¥67.10 Million | ▼ -65.7% |
| 2009 | 2.52x | CN¥97.25 Million | CN¥38.63 Million | CN¥97.25 Million | ▲ +10.2% |
| 2008 | 2.29x | CN¥130.82 Million | CN¥57.24 Million | CN¥130.82 Million | ▲ +97.7% |
| 2007 | 1.16x | CN¥8.86 Million | CN¥7.66 Million | CN¥8.86 Million | — |